Newer classes of biotherapies will require innovations in processing technology.
Cell concentrations and resulting protein concentrations are higher in a concentrated fed-batch process than in a standard fed-batch culture system.
Liquid particle counters are ideal for protein aggregation studies.
The authors re-examine environmental controls in the context of technical advances in manufacturing.
Managing and prioritizing risk is essential to ensuring raw material quality. USP is developing new guidelines to make the work easier.
Large-scale implementation of Protein A chromatography offers several challenges.
The business impact of modeling and simulation tools is not well understood and requires clarification of their benefits to drug development.
Large-scale implementation of Protein A chromatography offers several challenges.
A case study evaluates the performance, control of operations, productivity, and cost savings of a single-use system.
The procurement organization rethinks sourcing for maximum efficiency and results.
The approaches for sample preparation of preclinical evaluation of safety and efficacy are addressed taking into consideration the shortcoming with the contemporary approaches.
Advances in glycan analysis are enhancing biologics development and quality control processes.
The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.
This article presents first-hand perspectives from industry users to suppliers of single-use sensors.